Literature DB >> 6083576

Hydromorphone effects on human conversational speech.

M L Stitzer, M E McCaul, G E Bigleow, I A Liebson.   

Abstract

The present study provides an objective assessment of the increased talkativeness associated with acute opiate drug administration. Speech of five methadone-maintenance subjects was recorded continuously for 1 h following the injection of 0, 10, 14, or 18 mg hydromorphone. Dose-related increases in subjects' speech were observed, while no systematic changes were seen in speech of an undrugged partner. Dose-related increases were also obtained on an adjective checklist measuring characteristic opiate signs and symptoms. The relationship between behavioral, subjective, and reinforcing drug effects is discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6083576     DOI: 10.1007/bf00555221

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  20 in total

1.  A comparative study of physiological and subjective effects of heroin and morphine administered intravenously in postaddicts.

Authors:  W R MARTIN; H F FRASER
Journal:  J Pharmacol Exp Ther       Date:  1961-09       Impact factor: 4.030

2.  Drinking and socializing in "introverted" and "extraverted" alcoholics.

Authors:  C C Thornton; A I Alterman; T E Skoloda; E Gottheil
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

3.  Resilience of family process. Effect of secobarbital.

Authors:  D Reiss; C Salzman
Journal:  Arch Gen Psychiatry       Date:  1973-03

4.  Effects of imipramine on anxiety and hostility levels.

Authors:  L A Gottschalk; G C Gleser; H W Wylie; S M Kaplan
Journal:  Psychopharmacologia       Date:  1965-03-30

5.  Physiological and subjective effects of hydromorphone in postaddict volunteers.

Authors:  M McCaul; M Stitzer; G Bigelow; I Liebson
Journal:  NIDA Res Monogr       Date:  1982-04

Review 6.  Internal stimulus control and subjective effects of drugs.

Authors:  C R Schuster; M W Fischman; C E Johanson
Journal:  NIDA Res Monogr       Date:  1981-07

7.  Effects of certain benzodiazepine derivatives on disorganization of thought as manifested in speech.

Authors:  L A Gottschalk
Journal:  Curr Ther Res Clin Exp       Date:  1977-02

8.  Drug-produced changes in human social behavior: facilitation by d-amphetamine.

Authors:  R R Griffiths; M Stitzer; K Corker; G Bigelow; I Liebson
Journal:  Pharmacol Biochem Behav       Date:  1977-10       Impact factor: 3.533

9.  Alcohol's effect on some formal aspects of verbal social communication.

Authors:  R C Smith; E S Parker; E P Noble
Journal:  Arch Gen Psychiatry       Date:  1975-11

10.  Linguistic analysis of speech in affective disorders.

Authors:  N G Andreasen; B Pfohl
Journal:  Arch Gen Psychiatry       Date:  1976-11
View more
  5 in total

1.  Effect of d-amphetamine, secobarbital, and marijuana on choice behavior: social versus nonsocial options.

Authors:  S J Heishman; M L Stitzer
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  Acute marijuana effects on social conversation.

Authors:  S T Higgins; M L Stitzer
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  Effects of alcohol on speaking in isolated humans.

Authors:  S T Higgins; M L Stitzer
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

4.  A window into the intoxicated mind? Speech as an index of psychoactive drug effects.

Authors:  Gillinder Bedi; Guillermo A Cecchi; Diego F Slezak; Facundo Carrillo; Mariano Sigman; Harriet de Wit
Journal:  Neuropsychopharmacology       Date:  2014-04-03       Impact factor: 7.853

5.  Detection of acute 3,4-methylenedioxymethamphetamine (MDMA) effects across protocols using automated natural language processing.

Authors:  Carla Agurto; Guillermo A Cecchi; Raquel Norel; Rachel Ostrand; Matthew Kirkpatrick; Matthew J Baggott; Margaret C Wardle; Harriet de Wit; Gillinder Bedi
Journal:  Neuropsychopharmacology       Date:  2020-01-24       Impact factor: 7.853

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.